Instituto Dante Pazzanese de Cardiologia

São Paulo, São Paulo CEP 04012-909

3 studies enrolling now · 11 studies all time

What they study most

Acute Myocardial Infarction (AMI), Atherosclerotic Cardiovascular Disease, Cardiovascular Risk, Coronary Restenosis, Heart Failure, Hypertension, Pulmonary, Obesity, Overweight, Pulmonary Arterial Hypertension, Sleep Apnea

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial — Completed
• SELUTION SLR™ 014 In-stent Restenosis — Running, not enrolling
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure — Stopped early
• A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH) — Completed
• To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension. — Stopped early